Do you think the drop in price is due to the dilution going from 197m shares to 437m shares is pretty substantial...even when you factor in the funding...
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025